Skip to main content
TipRanks
Go Ultimate75% OFF

Mangalam Organics Ltd (MANORG) AI Stock Analysis

0 Followers
IN:MANORG

Mangalam Organics Ltd

(NSE:MANORG)

Select Model
Rating:47Neutral
Price Target:INR 425.00â–²(0.07% Upside)
Action:reiterated
Date:09/06/26

Mangalam Organics earns a below-average score of 47, primarily driven by negative operating cash flows and an increasing reliance on external debt to fund operations. While the top-line recovery is a positive sign, the neutral technical setup and moderate valuation offer limited near-term upside until management can effectively convert accounting profits into cash and stabilize the balance sheet.

Positive Factors
Steady Revenue GrowthSteady revenue growth indicates continued demand for the company’s products and improving commercial scale. If maintained, this expansion can support better operating leverage, broaden customer penetration, and provide a durable base for rebuilding profitability over the next several quarters.
Negative Factors
materially Higher LeverageThe sharp increase in debt relative to equity raises financial risk and reduces flexibility if operating conditions weaken. Greater leverage can absorb more future cash flow through financing obligations, limiting the company’s ability to fund growth or withstand another earnings downturn.

Mangalam Organics Ltd (MANORG) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%40%IN:MANORG-6.57%INDA-5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 3.68B
Dividend Yield
―
Average Volume (3M)
545
Price to Earnings (P/E)
18.1
Beta (1Y)
1.06
Revenue Growth
34.60%
EPS Growth
-13.51%
Country
India
Employees
347
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Mangalam Organics Ltd Business Overview & Revenue Model

Company Description

Mangalam Organics Limited, together with its subsidiaries, manufactures and sells chemicals for the industrial and consumer markets in India and internationally. The company offers terpene products, including camphor, camphene, dipentene, isobornyl a...

Mangalam Organics Ltd Financial Statement Overview

Summary

Financial performance is significantly hampered by severe cash flow constraints (score: 25) and a strained, highly leveraged balance sheet (score: 42), which overshadow the steady revenue growth and profitability recovery (score: 68).

Income Statement

68Positive

Balance Sheet

42Neutral

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.55B6.23B5.30B4.94B4.93B4.91B
Gross Profit2.42B2.17B2.57B1.13B701.20M1.47B
EBITDA857.00M890.69M589.13M390.38M-24.27M924.25M
Net Income207.96M257.56M125.97M42.86M-272.25M537.43M
Balance Sheet
Total Assets07.40B6.24B4.85B5.06B5.60B
Cash, Cash Equivalents and Short-Term Investments25.91M24.68M189.27M20.19M12.79M12.78M
Total Debt03.59B2.72B1.73B1.90B2.12B
Total Liabilities-3.19B4.21B3.30B2.05B2.30B2.56B
Stockholders Equity3.19B3.19B2.93B2.81B2.76B3.04B
Cash Flow
Free Cash Flow-769.42M-907.41M-751.15M327.48M361.57M-1.84B
Operating Cash Flow-281.34M-272.47M-78.44M727.23M769.23M-841.04M
Investing Cash Flow-381.05M-600.78M-670.47M-395.09M-407.80M-995.25M
Financing Cash Flow673.44M879.76M736.26M-325.52M-355.77M1.83B

Mangalam Organics Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price424.70

Price Trends

50DMA452.35Negative
100DMA481.07Negative
200DMA474.07Negative

Market Momentum

MACD-4.86Positive
RSI39.42Neutral
STOCH25.92Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Negative. The current price of 424.70 is below the 20-day moving average (MA) of 452.75, below the 50-day MA of 452.35, and below the 200-day MA of 474.07, indicating a bearish trend. The MACD of -4.86 indicates Positive momentum. The RSI at 39.42 is Neutral, neither overbought nor oversold. The STOCH value of 25.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MANORG.

Mangalam Organics Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:MANORG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:JAYAGROGNIN:JAYAGROGN67NeutralINR 7.09B10.87―1.49%18.12%27.74%
IN:ROSSARIIN:ROSSARI65NeutralINR 23.98B15.70―0.12%19.76%11.74%
IN:CHEMCONIN:CHEMCON61NeutralINR 7.16B24.02―3.31%22.25%20.33%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:FAIRCHEMORIN:FAIRCHEMOR53NeutralINR 8.34B35.38―0.15%17.44%304.08%
IN:MANORGIN:MANORG47NeutralINR 3.64B18.12――34.60%-13.51%
IN:AARTISURFIN:AARTISURF46NeutralINR 4.76B25.86―0.18%35.30%95.10%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%IN:MANORGIN:AARTISURFIN:CHEMCONIN:FAIRCHEMORIN:JAYAGROGNIN:ROSSARIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:MANORG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:MANORGMangalam Organics Ltd424.70-22.80-5.09%
IN:AARTISURFAarti Surfactants Ltd.561.90112.1324.93%
IN:CHEMCONChemcon Speciality Chemicals Ltd195.55-27.28-12.24%
IN:FAIRCHEMORFairchem Organics Ltd662.15-34.40-4.94%
IN:JAYAGROGNJayant Agro-Organics Limited236.3021.399.95%
IN:ROSSARIRossari Biotech Ltd432.90-188.65-30.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026